ABLIVA AB revenue breakdown overview

ABLIVA AB revenue for the last year amounted to 98.70 k USD, the most of which — 13.52 k USD — came from its highest performing source at the moment, Mitochondrial Diseases, the year earlier bringing 2.96 k USD. The greatest contribution to the revenue figure was made by Sweden — last year it brought ABLIVA AB 13.52 k USD, and the year before that — 2.96 k USD.